NCT03987789

Brief Summary

The aim of this study is to compare the effects of a strategy aimed at increasing alveolar recruitment (high PEEP levels adjusted according to driving pressure and recruitment maneuvers) with that of a strategy aimed at minimizing alveolar distension (low PEEP level without recruitment maneuver) on postoperative respiratory failure and mortality in patients receiving low VT ventilation during emergency abdominal surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
707

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

28 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 12, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 17, 2019

Completed
1.7 years until next milestone

Study Start

First participant enrolled

February 18, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 27, 2022

Completed
Last Updated

April 21, 2026

Status Verified

April 1, 2026

Enrollment Period

1.4 years

First QC Date

June 12, 2019

Last Update Submit

April 16, 2026

Conditions

Keywords

Mechanical VentilationLung-Protective VentilationPostoperative Pulmonary ComplicationsPostoperative morbidity

Outcome Measures

Primary Outcomes (1)

  • Postoperative respiratory failure

    Composite criteria : 1. \- Failure to wean from the ventilator after surgery (Yes or No) 2. \- Requiring unplanned reintubation (Yes or No) 3. \- Curative non-invasive ventilation once extubated postoperatively (Yes or No) 4. \- Death (all cause of mortality) (Yes or No) If at least one of these 4 criteria is answered yes, the composite criterion (i.e. the primary outcome) will be answered yes

    Hospital discharge - Up to day 30

Secondary Outcomes (25)

  • Postoperative pulmonary complications

    Day 30

  • Postoperative extra-pulmonary complications

    Day 30

  • SOFA

    Day 1

  • SOFA

    Day 2

  • SOFA

    Day 3

  • +20 more secondary outcomes

Study Arms (2)

Low PEEP group

ACTIVE COMPARATOR

Patients will receive a PEEP level ≤5 cmH2O without recruitment maneuvers

Other: Low PEEP

Driving-pressure-guided group

EXPERIMENTAL

Patients will receive PEEP levels individually set at the highest possible value (up to 15 cmH2O) providing a driving pressure (airway plateau pressure minus PEEP) lower than 13 cmH2O, in addition to recruitment maneuvers

Other: Driving-pressure-guided group

Interventions

Patients will receive PEEP levels individually set at the highest possible value (up to 15 cmH2O) providing a driving pressure (airway plateau pressure minus PEEP) lower than 13 cmH2O, in addition to recruitment maneuvers.

Driving-pressure-guided group

Patients will receive a PEEP level ≤5 cmH2O without recruitment maneuvers

Low PEEP group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult (≥18 years)
  • Patients requiring emergency (defined by the need to proceed to surgery within a few hours after diagnosis)
  • Laparoscopic or non-laparoscopic abdominal surgery under general anesthesia and with an expected duration of at least two hours

You may not qualify if:

  • Patients already receiving mechanical ventilation for more than 12 hours before enrollment
  • Intracranial hypertension
  • Chronic respiratory disease requiring oxygen therapy or mechanical ventilation at home
  • Undrained pneumothorax or subcutaneous emphysema
  • Patients for which death is deemed imminent and inevitable or patients with an underlying disease process with a life expectancy of less than 3 month
  • Body mass index (BMI) \>40 kg/m2
  • Pregnant or breastfeeding women
  • Patients already enrolled in the IMPROVE-2 trial
  • Participation in a confounding trial with mortality or PRF as the main endpoint
  • Patient's or relative's refusal to participate
  • Guardianship or trusteeship patient
  • No affiliation to the Social Security system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (28)

University hospital

Angers, France

Location

Hospital

Annecy, France

Location

University hospital

Besançon, France

Location

University Hospital

Bordeaux, France

Location

Hospital

Chalon-sur-Saône, France

Location

University hospital

Clermont-Ferrand, France

Location

University hospital

Dijon, France

Location

University hospital

Grenoble, France

Location

University hospital

Le Mans, France

Location

University hospital

Lille, France

Location

University hospital

Lyon, France

Location

University hospital

Marseile, France

Location

Assistance Publique-Hôpitaux de Marseille

Marseille, France

Location

Institut Paoli Calmette

Marseille, France

Location

University hospital

Marseille, France

Location

University hospital

Montpellier, France

Location

University Hospital

Nantes, France

Location

University hospital

Nice, France

Location

University hospital

Nîmes, France

Location

Assistance Publique-Hôpitaux de Paris

Paris, France

Location

Hospital

Périgueux, France

Location

University hospital

Pointe à Pitre, 97159, France

Location

University hospital

Rennes, France

Location

University hospital

Saint-Etienne, France

Location

University hospital

Strasbourg, France

Location

Hospital

Suresnes, France

Location

University hospital

Toulouse, France

Location

Hospital

Valenciennes, France

Location

Related Publications (2)

  • Futier E, De Jong A, Cirenei C, Godet T, Jabaudon M, Constantin JM, Grillot N, Bouzat P, Henry L, Margetis D, Lebuffe G, Garnier M, Lambert C, Pereira B, Jaber S; IMPROVE-2 Trial investigators. Personalized driving pressure-guided positive end-expiratory pressure in patients at risk of postoperative respiratory failure (IMPROVE-2): a multicenter, pragmatic, randomized clinical trial. Intensive Care Med. 2025 Oct;51(10):1797-1808. doi: 10.1007/s00134-025-08082-x. Epub 2025 Aug 21.

  • Khaled L, Godet T, Jaber S, Chanques G, Asehnoune K, Bourdier J, Araujo L, Futier E, Pereira B. Intraoperative protective mechanical ventilation in patients requiring emergency abdominal surgery: the multicentre prospective randomised IMPROVE-2 study protocol. BMJ Open. 2022 May 6;12(5):e054823. doi: 10.1136/bmjopen-2021-054823.

Study Officials

  • Emmanuel Futier

    CHU de Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
It will not be possible to mask the assigned ventilation strategy from the treating clinicians because they have an ethical responsibility to ensure patient safety during the emergency procedures. However, procedures will be put in place to minimize the possibility of bias arising because research staff becomes aware of trial group allocation. At each participating center, patients will be followed up for primary and secondary endpoints by members of the research staff who will be unaware of the trial group allocation. Information on whether the primary and secondary outcomes occur will be collected and entered into the electronic web-based case report form (eCRF) by trial or clinical trained personal (clinical research associate), blinded to the allocation group, under the supervision of the local principal investigator (PI) or designee who will also be unaware of the trial group allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Multicenter, prospective, randomized, stratified, parallel-group clinical trial with blinded outcome assessment and concealed allocation of patients undergoing emergency abdominal surgery using low VT lung-protective ventilation to a strategy of minimal alveolar distension using low PEEP level or to a strategy aimed at increasing alveolar recruitment (higher PEEP level individually titrated to minimize the driving pressure in addition to recruitment maneuvers)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 12, 2019

First Posted

June 17, 2019

Study Start

February 18, 2021

Primary Completion

July 29, 2022

Study Completion

October 27, 2022

Last Updated

April 21, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

The French National Data Safety Authority (CNIL) forbids making data freely available without prior agreement. Thus, the data underlying study findings cannot be made freely available because of ethical and legal restrictions. However, individual participant data underlying the results reported in the manuscript (text, tables, figures, and appendices) can be obtained after deidentification. Data can be obtained upon request from the IMPROVE-2 steering committee. Readers may contact: efutier@chu-clermontferrand.fr to request the data. The data cannot be freely available for the reasons mentioned above. Data access can be only possible after scientific assessment and data sharing agreement, detailing the type of data requested. This data sharing agreement has to be signed between applicants and the sponsor, Clermont-Ferrand University Hospital.

Shared Documents
STUDY PROTOCOL
Time Frame
Beginning 6 months following article publication. No end date
Access Criteria
. Data can be obtained upon request from the IMPROVE-2 steering committee. Readers may contact: efutier@chu-clermontferrand.fr to request the data.

Locations